These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8540108)

  • 1. Metabolic aspects of cultured hepatocytes for use in a bioartificial liver support system.
    Waring MA; Sun J; Woodman K; Mears DC; Johnston B; Jung SE; Horvat M; Koutalistras N; Watson KJ; Sheil AG
    Transplant Proc; 1995 Dec; 27(6):3572-3. PubMed ID: 8540108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver support effect of experimental extracorporeal bioartificial liver].
    Wang Y; Li M; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):31-3. PubMed ID: 10366983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bio-artificial organ replacement of the liver].
    Koebe HG; Thasler W; Schildberg FW
    Zentralbl Chir; 1993; 118(11):697-701. PubMed ID: 8303964
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson J; Koutalistras N; Wang L
    Int J Artif Organs; 1998 Jan; 21(1):43-8. PubMed ID: 9554825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure.
    Kelly JH; Sussman NL
    ASAIO J; 1994; 40(1):83-5. PubMed ID: 7514459
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic function--3: protein metabolism and blood ammonia tests.
    Wilkes RD; Goldston RT; Seybold IM
    Vet Med Small Anim Clin; 1981 Jul; 76(7):960-4. PubMed ID: 6914088
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial liver support.
    Sussman NL; Kelly JH
    Clin Invest Med; 1996 Oct; 19(5):393-9. PubMed ID: 8889280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bioartificial liver used as a bridge to liver transplantation in a 10-year-old boy.
    LePage EB; Rozga J; Rosenthal P; Watanabe F; Scott HC; Talke AM; Demetriou AA
    Am J Crit Care; 1994 May; 3(3):224-7. PubMed ID: 8038852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
    Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson KJ; Koutalistras N; Wang LS
    Aust N Z J Surg; 1996 Aug; 66(8):547-52. PubMed ID: 8712990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hybrid artificial liver system. Function of cultured monolayer pig hepatocytes in plasma from hepatic failure patients.
    Uchino J; Matsue H; Takahashi M; Nakajima Y; Matsushita M; Hamada T; Hashimura E
    ASAIO Trans; 1991; 37(3):M337-8. PubMed ID: 1751175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a novel bioartificial liver in a patient with acute liver insufficiency.
    Neuzil DF; Rozga J; Moscioni AD; Ro MS; Hakim R; Arnaout WS; Demetriou AA
    Surgery; 1993 Mar; 113(3):340-3. PubMed ID: 8441969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microencapsulated hepatocytes as a bioartificial liver.
    Sun AM; Cai Z; Shi Z; Ma F; O'Shea GM; Gharapetian H
    ASAIO Trans; 1986; 32(1):39-41. PubMed ID: 3535849
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assessment of liver function by metabolic parameters].
    Kleinberger G
    Klin Anasthesiol Intensivther; 1987; 34():46-58. PubMed ID: 3682706
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy.
    Kanai H; Marushima H; Kimura N; Iwaki T; Saito M; Maehashi H; Shimizu K; Muto M; Masaki T; Ohkawa K; Yokoyama K; Nakayama M; Harada T; Hano H; Hataba Y; Fukuda T; Nakamura M; Totsuka N; Ishikawa S; Unemura Y; Ishii Y; Yanaga K; Matsuura T
    Artif Organs; 2007 Feb; 31(2):148-51. PubMed ID: 17298404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated large-scale production of porcine hepatocytes for bioartificial liver support.
    Morsiani E; Rozga J; Scott HC; Kong LB; Lebow LT; McGrath MF; Moscioni AD; Demetriou AA
    Transplant Proc; 1994 Dec; 26(6):3505-6. PubMed ID: 7998250
    [No Abstract]   [Full Text] [Related]  

  • 17. Does the extend of the culture time of primary hepatocytes in a bioreactor affect the treatment efficacy of a bioartificial liver?
    Flendrig LM; Maas MA; Daalhuisen J; Ladiges NC; La Soe JW; Te Velde AA; Chamuleau RA
    Int J Artif Organs; 1998 Sep; 21(9):542-7. PubMed ID: 9828060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-induced liver cell aggregates (MILCA) for bioartificial liver use.
    Kong LB; Chen S; Demetriou AA; Rozga J
    Int J Artif Organs; 1996 Jan; 19(1):72-8. PubMed ID: 8641823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.
    Nyberg SL; Remmel RP; Mann HJ; Peshwa MV; Hu WS; Cerra FB
    Ann Surg; 1994 Jul; 220(1):59-67. PubMed ID: 8024360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transport proteins in bioartificial liver assist systems.
    Mitzner S; Stange J; Freytag J; Lindemann S; Schmidt R
    Int J Artif Organs; 1996 Jan; 19(1):49-52. PubMed ID: 8641819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.